Biotech Acquisition Co Analysis
| BIOTDelisted Stock | USD 10.15 0.00 0.00% |
Biotech Acquisition Co is overvalued with Real Value of 8.66 and Hype Value of 10.15. The main objective of Biotech Acquisition delisted stock analysis is to determine its intrinsic value, which is an estimate of what Biotech Acquisition Co is worth, separate from its market price. There are two main types of Biotech Acquisition's stock analysis: fundamental analysis and technical analysis.
The Biotech Acquisition stock is traded in the USA on NASDAQ Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Biotech Acquisition is usually not traded on Labour Day, Thanksgiving Day, Christmas Day, New Year 's Day, National Mourning Day, Dr . Martin Luther King Jr 's Birthday, Washington 's Birthday, Good Friday, Memorial Day, Juneteenth Holiday, Independence Day. Biotech Stock trading window is adjusted to America/New York timezone.
Biotech |
Biotech Stock Analysis Notes
About 100.0% of the company shares are held by institutions such as insurance companies. The company has price-to-book (P/B) ratio of 1.33. Some equities with similar Price to Book (P/B) outperform the market in the long run. Biotech Acquisition had not issued any dividends in recent years. The entity had 1:0 split on the 9th of August 2010. Biotech Acquisition Company does not have significant operations. The company was incorporated in 2020 and is based in New York, New York. Biotech Acquisition is traded on NASDAQ Exchange in the United States. For more info on Biotech Acquisition Co please contact Michael Shleifer at 212 227 1905.Biotech Acquisition Investment Alerts
| Biotech Acquisition is not yet fully synchronised with the market data | |
| Biotech Acquisition has a very high chance of going through financial distress in the upcoming years | |
| Biotech Acquisition Co currently holds 153.35 K in liabilities with Debt to Equity (D/E) ratio of 3.48, implying the company greatly relies on financing operations through barrowing. Biotech Acquisition has a current ratio of 0.04, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Note, when we think about Biotech Acquisition's use of debt, we should always consider it together with its cash and equity. | |
| Net Loss for the year was (6.86 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Biotech Acquisition Co currently holds about 1.7 K in cash with (1.47 M) of positive cash flow from operations. |
Biotech Market Capitalization
The company currently falls under 'Small-Cap' category with a current market capitalization of 291.81 M.Biotech Acquisition Outstanding Bonds
Biotech Acquisition issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Biotech Acquisition uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Biotech bonds can be classified according to their maturity, which is the date when Biotech Acquisition Co has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| Dana 575 percent Corp BondUS235822AB96 | View | |
| Boeing Co 2196 Corp BondUS097023DG73 | View | |
| HSBC Holdings PLC Corp BondUS404280DR76 | View | |
| MPLX LP 4125 Corp BondUS55336VAK61 | View | |
| MPLX LP 52 Corp BondUS55336VAL45 | View | |
| International Game Technology Corp BondUS460599AD57 | View | |
| BNP Paribas FRN Corp BondUSF1R15XK367 | View | |
| Morgan Stanley 3591 Corp BondUS61744YAK47 | View |
Biotech Acquisition Predictive Daily Indicators
Biotech Acquisition intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Biotech Acquisition stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
About Biotech Stock Analysis
Stock analysis is the technique used by a trader or investor to examine and evaluate how Biotech Acquisition prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Biotech shares will generate the highest return on investment. We also built our delisted stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Delisted Stock such as Biotech Acquisition. By using and applying Biotech Stock analysis, traders can create a robust methodology for identifying Biotech entry and exit points for their positions.
Biotech Acquisition Company does not have significant operations. The company was incorporated in 2020 and is based in New York, New York. Biotech Acquisition is traded on NASDAQ Exchange in the United States.
Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding Biotech Acquisition to your portfolios without increasing risk or reducing expected return.Did you try this?
Run Theme Ratings Now
Theme RatingsDetermine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance |
| All Next | Launch Module |
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons. You can also try the Companies Directory module to evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals.
Other Consideration for investing in Biotech Stock
If you are still planning to invest in Biotech Acquisition check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Biotech Acquisition's history and understand the potential risks before investing.
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA |